UHRF1 Knockdown Attenuates Cell Growth, Migration, and Invasion in Cutaneous Squamous Cell Carcinoma

References

• Hopfner R, Mousli M, Garnier JM, Redon R, Du Manoir S, Chatton B, et al. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression. Gene. 2001;266(1-2):15–23. doi:10.1016/s0378-1119(01)00371-7.
   PubMed Web of Science ®Google Scholar
• Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature. 2007;450(7171):908–912. doi:10.1038/nature06397.
   PubMed Web of Science ®Google Scholar
• Sen GL, Reuter JA, Webster DE, Zhu L, Khavari PA. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature. 2010;463(7280):563–567. doi:10.1038/nature08683.
   PubMed Web of Science ®Google Scholar
• Sharif J, Koseki H. Recruitment of Dnmt1 roles of the SRA protein Np95 (Uhrf1) and other factors. Prog Mol Biol Transl Sci. 2011;101:289–310. doi:10.1016/B978-0-12-387685-0.00008-1.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao Q, Li P, Liu X, Jia Y, Wu W, et al. S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res. 2011;21(12):1723–1739. doi:10.1038/cr.2011.176.
   PubMed Web of Science ®Google Scholar
• Liu X, Gao Q, Li P, Zhao Q, Zhang J, Li J, et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat Commun. 2013;4:1563.doi:10.1038/ncomms2562.
   PubMed Web of Science ®Google Scholar
• Bashtrykov P, Jankevicius G, Jurkowska RZ, Ragozin S, Jeltsch A. The UHRF1 protein stimulates the activity and specificity of the maintenance DNA methyltransferase DNMT1 by an allosteric mechanism. J Biol Chem. 2014;289(7):4106–4115. doi:10.1074/jbc.M113.528893.
   PubMed Web of Science ®Google Scholar
• Meilinger D, Fellinger K, Bultmann S, Rothbauer U, Bonapace IM, Klinkert WE, et al. Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells. EMBO Rep. 2009;10(11):1259–1264. doi:10.1038/embor.2009.201.
   PubMed Web of Science ®Google Scholar
• Newkirk SJ, An W. UHRF1: a jack of all trades, and a master epigenetic regulator during spermatogenesis. Biol Reprod. 2020;102(6):1147–1152. doi:10.1093/biolre/ioaa026.
   PubMed Web of Science ®Google Scholar
• Polepalli S, George SM, Valli Sri Vidya R, Rodrigues GS, Ramachandra L, Chandrashekar R, et al. Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain. Int J Biochem Cell Biol. 2019;114:105558.doi:10.1016/j.biocel.2019.06.006.
   PubMed Web of Science ®Google Scholar
• Sidhu H, Capalash N. UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics. Tumour Biol. 2017;39(2):1010428317692205. doi:10.1177/1010428317692205.
   Google Scholar
• Xue B, Zhao J, Feng P, Xing J, Wu H, Li Y. Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies. Onco Targets Ther. 2019;12:549–559. doi:10.2147/ott.s192234.
   PubMed Web of Science ®Google Scholar
• Goto D, Komeda K, Uwatoko N, Nakashima M, Koike M, Kawai K, et al. UHRF1, a regulator of methylation, as a diagnostic and prognostic marker for lung cancer. Cancer Invest. 2020;38(4):240–249. doi:10.1080/07357907.2020.1747483.
   PubMed Web of Science ®Google Scholar
• Lee K, Adhikary G, Balasubramanian S, Gopalakrishnan R, McCormick T, Dimri GP, et al. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol. 2008;128(1):9–17. doi:10.1038/sj.jid.5700949.
   PubMed Web of Science ®Google Scholar
• Chu Z, Zhang X, Li Q, Hu G, Lian CG, Geng S. CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β-catenin signaling pathway. Int J Oncol. 2019;54(5):1534–1544. doi:10.3892/ijo.2019.4727.
   PubMed Web of Science ®Google Scholar
• Hu G, Liang L, Liu Y, Liu J, Tan X, Xu M, et al. TWEAK/Fn14 interaction confers aggressive properties to cutaneous squamous cell carcinoma. J Invest Dermatol. 2019;139(4):796–806. doi:10.1016/j.jid.2018.09.035.
   PubMed Web of Science ®Google Scholar
• Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–1116. doi:10.1038/nprot.2006.179.
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/S1476-5586(04)80047-2.
   PubMed Web of Science ®Google Scholar
• Unoki M, Nishidate T, Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene. 2004;23(46):7601–7610. doi:10.1038/sj.onc.1208053.
   PubMed Web of Science ®Google Scholar
• Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, et al. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells. 2004;9(2):131–142. doi:10.1111/j.1356-9597.2004.00710.x.
   PubMed Web of Science ®Google Scholar
• Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122(2):464–472. doi:10.1172/jci57415.
   PubMed Web of Science ®Google Scholar
• Qin Y, Wang J, Gong W, Zhang M, Tang Z, Zhang J, et al. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest. Oncol Rep. 2014;31(6):2635–2643. doi:10.3892/or.2014.3145.
   PubMed Web of Science ®Google Scholar
• Yan F, Shao LJ, Hu XY. Knockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growth. Asian Pac J Cancer Prev. 2015;16(4):1343–1348. doi:10.7314/apjcp.2015.16.4.1343.
   PubMedGoogle Scholar
• He H, Lee C, Kim JK. UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4. Cell Death Dis. 2018;9(2):164.doi:10.1038/s41419-017-0203-4.
   PubMedGoogle Scholar
• Cai Y, Tsai HC, Yen RC, Zhang YW, Kong X, Wang W, et al. Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells. Genome Res. 2017;27(4):533–544. doi:10.1101/gr.208108.116.
   PubMed Web of Science ®Google Scholar
• Liu X, Ou H, Xiang L, Li X, Huang Y, Yang D. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma. Oncotarget. 2017;8(6):10510–10522. doi:10.18632/oncotarget.14446.
   PubMedGoogle Scholar
• Gao SP, Sun HF, Li LD, Fu WY, Jin W. UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter. Am J Cancer Res. 2017;7(7):1554–1565.
   PubMed Web of Science ®Google Scholar
• Li XL, Xu JH, Nie JH, Fan SJ. Exogenous expression of UHRF1 promotes proliferation and metastasis of breast cancer east cancer cells. Oncol Rep. 2012;28(1):375–383. doi:10.3892/or.2012.1792.
   PubMed Web of Science ®Google Scholar
• Kong X, Chen J, Xie W, Brown SM, Cai Y, Wu K, et al. Defining UHRF1 domains that support maintenance of human colon cancer DNA methylation and oncogenic properties. Cancer Cell. 2019;35(4):633–648.e7. doi:10.1016/j.ccell.2019.03.003.
   PubMed Web of Science ®Google Scholar
• Kim JH, Shim JW, Eum DY, Kim SD, Choi SH, Yang K, et al. Downregulation of UHRF1 increases tumor malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling axis in hepatocellular carcinoma cells. Sci Rep. 2017;7(1):2798. doi:10.1038/s41598-017-02935-2.
   PubMedGoogle Scholar
• Jung YD, Shim JW, Park SJ, Choi SH, Yang K, Heo K, et al. Downregulation of UHRF1 promotes EMT via inducing CXCR4 in human cancer cells. Int J Oncol. 2015;46(3):1232–1242. doi:10.3892/ijo.2014.2813.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Z, Zhu Z, Zheng X, Liu J, Han Z, et al. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1. PloS One. 2014;9(10):e104252.doi:10.1371/journal.pone.0104252.
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhao X, Han Y, Lu Y, Shang Y, Liu C, et al. Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis. Faseb J. 2013;27(12):4929–4939. doi:10.1096/fj.13-233387.
   PubMed Web of Science ®Google Scholar
• Lee JH, Piao MS, Choi JY, Yun SJ, Lee JB, Lee SC. Up-regulation of cyclooxygenase 2 and matrix metalloproteinases-2 and -9 in cutaneous squamous cell carcinoma: active role of inflammation and tissue remodeling in carcinogenesis. Ann Dermatol. 2013;25(2):145–151. doi:10.5021/ad.2013.25.2.145.
   PubMed Web of Science ®Google Scholar
• Hafner C, Landthaler M, Vogt T. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations. Exp Dermatol. 2010;19(8):e222–e227. doi:10.1111/j.1600-0625.2009.01056.x.
   PubMed Web of Science ®Google Scholar
• Savar A, Acin S, Gonzalez CL, El-Sawy T, Mejia O, Li Z, et al. Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment. Oncogene. 2015;34(4):516–524. doi:10.1038/onc.2013.585.
   PubMed Web of Science ®Google Scholar
• Rittie L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, et al. Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am J Pathol. 2007;170(6):2089–2099. doi:10.2353/ajpath.2007.060537.
   PubMed Web of Science ®Google Scholar
• Zou Y, Ge M, Wang X. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo. Biochem Biophys Res Commun. 2017;490(2):385–392. doi:10.1016/j.bbrc.2017.06.052.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liang G, Zhou T, Liu Z. Silencing UHRF1 inhibits cell proliferation and promotes cell apoptosis in retinoblastoma via the PI3K/Akt signalling pathway. Pathol Oncol Res. 2019;26(2):1079–1088. doi:10.1007/s12253-019-00656-7.
   PubMed Web of Science ®Google Scholar
• Cui Y, Chen X, Zhang J, Sun X, Liu H, Bai L, et al. Uhrf1 controls iNKT cell survival and differentiation through the Akt-mTOR axis. Cell Rep. 2016;15(2):256–263. doi:10.1016/j.celrep.2016.03.016.
   PubMed Web of Science ®Google Scholar
• Wang N, Li Y, Wei J, Pu J, Liu R, Yang Q, et al. TBX1 functions as a tumor suppressor in thyroid cancer through inhibiting the activities of the PI3K/AKT and MAPK/ERK pathways. Thyroid. 2019;29(3):378–394. doi:10.1089/thy.2018.0312.
   PubMed Web of Science ®Google Scholar